These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332 [TBL] [Abstract][Full Text] [Related]
4. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database. Salehi O; Kazakova V; Vega EA; Kutlu OC; Alarcon SV; Freeman R; Kozyreva O; Conrad C Surg Endosc; 2022 Jul; 36(7):5382-5391. PubMed ID: 34750709 [TBL] [Abstract][Full Text] [Related]
5. Facility Volume Thresholds for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Hepatectomy for Primary Liver Tumors. Hoerger K; Hue JJ; Elshami M; Ammori JB; Hardacre JM; Winter JM; Ocuin LM J Gastrointest Surg; 2023 Feb; 27(2):273-282. PubMed ID: 36443556 [TBL] [Abstract][Full Text] [Related]
6. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma. Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study. Yoh T; Cauchy F; Le Roy B; Seo S; Taura K; Hobeika C; Dokmak S; Farges O; Gelli M; Sa Cunha A; Adam R; Uemoto S; Soubrane O Surgery; 2019 Dec; 166(6):975-982. PubMed ID: 31421869 [TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261 [TBL] [Abstract][Full Text] [Related]
12. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Kim DH; Choi DW; Choi SH; Heo JS; Kow AW Surgery; 2015 Apr; 157(4):666-75. PubMed ID: 25682172 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma. Conci S; ViganĂ² L; Ercolani G; Gonzalez E; Ruzzenente A; Isa G; Salaris C; Fontana A; Bagante F; Pedrazzani C; Campagnaro T; Iacono C; De Santibanes E; Pinna DA; Torzilli G; Guglielmi A Eur J Surg Oncol; 2020 Sep; 46(9):1727-1733. PubMed ID: 32360063 [TBL] [Abstract][Full Text] [Related]
14. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival. Wu L; Tsilimigras DI; Paredes AZ; Mehta R; Hyer JM; Merath K; Sahara K; Bagante F; Beal EW; Shen F; Pawlik TM World J Surg; 2019 Jul; 43(7):1777-1787. PubMed ID: 30820734 [TBL] [Abstract][Full Text] [Related]
15. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352 [TBL] [Abstract][Full Text] [Related]
16. Defining Facility Volume Threshold for Optimization of Short- and Long-Term Outcomes in Patients Undergoing Resection of Perihilar Cholangiocarcinoma. Elshami M; Hue JJ; Ahmed FA; Kakish H; Hoehn RS; Rothermel LD; Hardacre JM; Ammori JB; Winter JM; Ocuin LM J Gastrointest Surg; 2023 Apr; 27(4):730-740. PubMed ID: 36138311 [TBL] [Abstract][Full Text] [Related]
17. Textbook oncologic outcomes among patients undergoing laparoscopic, robotic and open surgery for intrahepatic and perihilar cholangiocarcinoma. Munir MM; Dillhoff M; Tsai S; Pawlik TM HPB (Oxford); 2024 Aug; 26(8):1051-1061. PubMed ID: 38825434 [TBL] [Abstract][Full Text] [Related]
18. Survival analysis of intrahepatic cholangiocarcinoma after resection. Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987 [TBL] [Abstract][Full Text] [Related]
19. A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality. Turner KM; Delman AM; Kharofa J; Olowokure O; Sohal D; Quillin RC; Shah SA; Ahmad SA; Patel SH; Wilson GC Ann Surg Oncol; 2022 Aug; 29(8):5094-5102. PubMed ID: 35441906 [TBL] [Abstract][Full Text] [Related]
20. Tumor location influences perioperative and oncologic outcomes in solitary intrahepatic cholangiocarcinoma following curative resection: a multi-center analysis. Li H; Liu R; Li J; Li J; Wu H; Wang G; Li D HPB (Oxford); 2022 Sep; 24(9):1543-1550. PubMed ID: 35393220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]